CoChat

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis

Telimaa, S., Puolakka, J., Kauppila, A. · 1987 · Gynecological Endocrinology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

A prospective, double-blind, placebo-controlled study was designed to evaluate the clinical efficacy and tolerance of danazol and high-dose medroxyprogesterone acetate (MPA) in the treatment of mild-moderate endometriosis. After laparoscopical confirmation of endometriosis, 59 patients were randomized to receive danazol (200 mg 3 times daily), MPA (100 mg daily) or placebo for 6 months. Clinical examinations were done before and 1, 3, 6 and 12 months after the beginning of the study, and a 2nd laparoscopy 6 months after termination of the medication. Eighteen patients in the danazol group, 16 in the MPA group and 17 in the placebo group completed the trial. Total or partial resolution of peritoneal implants was observed in 60% of the patients receiving danazol and in 63% of the patients receiving MPA. In the placebo group, resolution was observed in 18%, while the size of the implants was estimated to be increased in 23% of the patients. In relation to placebo, danazol and MPA significantly alleviated endometriosis-associated pelvic pain, lower back pain and defecation pain, but they did not differ from each other in these actions. The appearance of acne, muscle cramps, edema, weight gain and spotting bleeding complicated MPA treatment. The present results indicate that because of good efficacy and tolerance, high-dose MPA is a useful alternative in the hormonal treatment of endometriosis.

Overview

Integrity signals

Registry

Crossref · 10.3109/09513598709082692

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 4

  1. Dmowski W. P., 1975, Am.J. Obstet. Gynecol., 46, 147
  2. Rönnberg L., 1979, Postgrad. Med. J., 55, 21
  3. Moghissi K. S., 1976, Obstet. Gynecol., 47, 265
  4. Roland M., 1976, J. Reprod. Med., 17, 249

Cited by

See all 241

Metadata

Authors
Telimaa, S., Puolakka, J., & Kauppila, A.
Affiliations
University of Oulu (FI)
Venue
Gynecological Endocrinology
Published
1987-01
Volume
1
Issue
1
Pages
13-23
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W1990658851
Cited by
241
References
31
Citations by year
2026: 5 · 2025: 1 · 2024: 6 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 12 · 2016: 2 · 2015: 9 · 2014: 6 · 2013: 4 · 2012: 7
FWCI
6.22
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, danazol, medroxyprogesterone acetate, hormone therapy, peritoneal implants, pelvic pain, drug tolerability, treatment efficacy
MeSH terms
Adult, Antineoplastic Agents, Clinical Trials as Topic, Danazol, Dose-Response Relationship, Drug, Double-Blind Method, Endometriosis, Female, Humans, Infertility, Female, Medroxyprogesterone, Ovarian Neoplasms, Pelvic Neoplasms, Laparoscopy, Pregnadienes, Pregnancy, Random Allocation, Medroxyprogesterone Acetate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. https://app.cochat.ai/papers/10.3109/09513598709082692
The paper
Telimaa, S., Puolakka, J., & Kauppila, A. (1987). Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecological Endocrinology. https://doi.org/10.3109/09513598709082692

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.